1998
DOI: 10.3171/jns.1998.88.1.0038
|View full text |Cite
|
Sign up to set email alerts
|

Increase in diameters of vasospastic intracranial arteries by intraarterial papaverine administration

Abstract: In all treatment groups an increase was found in the average arterial diameters ranging from 2.8 to 73.9%, with a mean increase of 26.5%. Increases in diameter were observed in proximal, intermediate, and distal arteries. The timing of treatments ranged from Day 3 to Day 19 post-SAH, and there was no relationship between timing and arterial responsiveness (r = -0.06). There was a moderately good correlation between the degree of vasospasm in an artery and its responsiveness to papaverine (r = -0.54, -0.66, and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
42
0

Year Published

2001
2001
2012
2012

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 88 publications
(43 citation statements)
references
References 17 publications
1
42
0
Order By: Relevance
“…Vasospasm is subjectively graded as mild, moderate, or severe. 17 After vasospasm is angiographically diagnosed, a choice is made between medical and endovascular treatment. This decision is reached through discussion among the attending interventional neuroradiologist, neurosurgeon, and neurointensivist.…”
Section: Endovascular Vasospasm Treatmentmentioning
confidence: 99%
“…Vasospasm is subjectively graded as mild, moderate, or severe. 17 After vasospasm is angiographically diagnosed, a choice is made between medical and endovascular treatment. This decision is reached through discussion among the attending interventional neuroradiologist, neurosurgeon, and neurointensivist.…”
Section: Endovascular Vasospasm Treatmentmentioning
confidence: 99%
“…Vessels with more vasospasm and narrower lumens have been shown to respond to papaverine treatment with greater increases in vessel diameter. 37 The degree of arterial responsiveness, however, was independent of the post-SAH day of treatment.…”
Section: Clinical Effects and Outcomesmentioning
confidence: 98%
“…46 Although many anecdotal and retrospective reports in the literature have documented improved neurological outcomes after intraarterial papaverine, findings in studies of its clinical efficacy remain inconclusive and its precise role in treating vasospasm has yet to be determined in controlled prospective randomized trials. 45 Intraarterial papaverine has been noted to be effective in increasing angiographically demonstrated vessel diame-C. M. Sayama, J. K. Liu, and W. T. Couldwell ter; 8,37 to improve CBF by dilating the proximal, intermediate, and distal cerebral arteries; 8 to improve mean cerebral circulation time; 34,36 and to improve cerebral oxygenation. 14 In a study by Oskouian, et al, 42 intraarterial papaverine infusions increased vessel diameter in 20 patients by an average of 30.1%.…”
Section: Clinical Effects and Outcomesmentioning
confidence: 99%
See 1 more Smart Citation
“…However, repeated injections have been associated with worse clinical outcomes in several case series [74][75][76]. Advancements in microcatheter technology have made the super selective catheterization of third and fourth order cerebral vessels possible, allowing for slow infusion of vasodilators, perhaps reducing side effects [70,71,77,78]. Case series report the use of other IA vasodilators, including verapamil, nicardipine, nimodipine, and milrinone [35,[79][80][81][82][83].…”
Section: Endovascular Therapiesmentioning
confidence: 99%